| Product Code: ETC13117614 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of pneumococcal vaccines in Ireland in 2024 showed a continued dominance from key exporting countries such as the USA, UK, Germany, Metropolitan France, and Serbia. Despite a high concentration level indicated by HHI, the market experienced a decline in CAGR from 2020 to 2024 at -4.18%. Furthermore, the growth rate from 2023 to 2024 was notably steep at -30.16%, suggesting a challenging market environment for pneumococcal vaccine imports in Ireland. Monitoring these trends closely will be crucial for stakeholders in the industry to navigate potential challenges and opportunities ahead.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pneumococcal Vaccines Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Ireland Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Ireland Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.7 Ireland Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Ireland Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ireland Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumococcal diseases |
4.2.2 Government initiatives and programs promoting vaccination coverage |
4.2.3 Growing elderly population and rising incidences of pneumococcal diseases |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines |
4.3.2 Limited access to healthcare services in certain regions |
4.3.3 Vaccine hesitancy and misinformation among some population segments |
5 Ireland Pneumococcal Vaccines Market Trends |
6 Ireland Pneumococcal Vaccines Market, By Types |
6.1 Ireland Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.4 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021 - 2031F |
6.1.5 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2021 - 2031F |
6.1.6 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.7 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Ireland Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2021 - 2031F |
6.2.3 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.2.5 Ireland Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2021 - 2031F |
6.2.6 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Ireland Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Government, 2021 - 2031F |
6.3.5 Ireland Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2021 - 2031F |
6.3.6 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Ireland Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2021 - 2031F |
6.4.3 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.4.4 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2021 - 2031F |
6.4.5 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2021 - 2031F |
6.4.6 Ireland Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 Ireland Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 Ireland Pneumococcal Vaccines Market Export to Major Countries |
7.2 Ireland Pneumococcal Vaccines Market Imports from Major Countries |
8 Ireland Pneumococcal Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rate among children and elderly population |
8.2 Number of healthcare providers offering pneumococcal vaccination services |
8.3 Rate of reported pneumococcal disease cases in Ireland |
9 Ireland Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 Ireland Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
9.3 Ireland Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Ireland Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ireland Pneumococcal Vaccines Market - Competitive Landscape |
10.1 Ireland Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here